RecruitingNot Applicable

Employment Support After Hematopoietic Stem Cell Transplantation

United States35 participantsStarted 2024-07-31

Plain-language summary

This is a feasibility study of a Work Support (WorkS) intervention designed to ameliorate employment challenges for people preparing to return to work after allogeneic stem cell transplantation. The aim of this study is to evaluate "proof of concept" by: 1. examining the feasibility and acceptability of the WorkS intervention and the study procedures, and 2. exploring the preliminary effects of WorkS for improving patient-reported return-to-work self-efficacy, work status, quality of life, and financial toxicity.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Received an allogeneic HSCT within the past six months to treat a hematological malignancy. * Screen positive for work-related concerns (i.e., responds "yes" to the question, "Are you concerned about your ability to return to work in the coming six months?") Exclusion Criteria: * Patients with acute psychiatric or cognitive conditions which the treating clinician believes prohibits informed consent or compliance with the study procedures * We will not enroll the following special populations: adults unable to consent, individuals not yet adults, pregnant women, and prisoners.

What they're measuring

Screening Rate

Timeframe: At screening

Eligibility Rate

Timeframe: At screening

Enrollment Rate

Timeframe: Up to 2 months

Intervention completion Rate

Timeframe: Up to 2 months

Assessment Completion Rate

Timeframe: Up to 6 months

Trial details

NCT IDNCT06494423

SponsorMGH Institute of Health Professions

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-12-31

Contact for this trial

Kathleen Lyons, ScD, OTR/L

614-643-5372 klyons2@mghihp.edu